Taryn L Mayes1, Betsy D Kennard2, Michael Killian3, Thomas Carmody4, Bruce D Grannemann5, A John Rush6, Manish K Jha7, Jennifer Hughes8, Graham J Emslie9, Madhukar H Trivedi10. 1. Department of Psychiatry at UT Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX, 75390-9119, United States. Electronic address: taryn.mayes.@utsouthwestern.edu. 2. UT Southwestern Medical Center and the Department of Psychiatry at Children's Health Systems of Texas, Children's Medical Center, 5323 Harry Hines Blvd., Dallas, TX, 75390-9119, United States. Electronic address: beth.kennard@utsouthwestern.edu. 3. School of Social Work at UT Arlington, 211 S. Cooper St., #201b, Arlington, TX, 76019, United States. Electronic address: killianm@uta.edu. 4. Department of Clinical Sciences at UT Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX, 75390-9119, United States. Electronic address: Thomas.carmody@utsouthwestern.edu. 5. Department of Psychiatry at UT Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX, 75390-9119, United States. Electronic address: bruce.grannemann@utsouthwestern.edu. 6. Professor emeritus, Duke-NUS, 7 Avenida Vista Grande, #112, Santa Fe, NM, 87508, United States. Electronic address: curbstoneconsultant@gmail.com. 7. Department of Psychiatry at UT Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX, 75390-9119, United States. Electronic address: manish.jha@utsouthwestern.edu. 8. Department of Psychiatry at UT Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX, 75390-9119, United States. Electronic address: Jennifer.hughes@utsouthwestern.edu. 9. Department of Psychiatry at UT Southwestern Medical Center, 6300 Harry Hines Blvd. Suite 1200, Dallas, TX 75235, United States. Electronic address: graham.emslie@utsouthwestern.edu. 10. Department of Psychiatry at UT Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX, 75390-9119, United States. Electronic address: madhukar.trivedi@utsouthwestern.edu.
Abstract
BACKGROUND: Several self-report rating scales have been developed to assess suicidal ideation, yet few examine other factors related to increased suicidal risk, and even fewer have been validated in both adolescents and adults. We evaluate the 14-item Concise Health Risk Tracking - Self Report (CHRT-SR), a measure previously validated in adults, in a sample of adolescents at risk for suicide. METHOD: Data are from a retrospective chart review of adolescents treated in an intensive outpatient program for youth with severe suicidality. Teens completed the CHRT-SR and Quick Inventory of Depressive Symptomatology - Adolescents (QIDS-A) at baseline and discharge. The CHRT-SR was evaluated to determine the factor validity, internal consistency, construct validity, and sensitivity to change. RESULTS: Adolescents (n = 271) completed the CHRT-SR prior to treatment, and 231 completed the CHRT-SR at discharge. Three factors were identified with excellent model fit: Propensity, Impulsivity, and Suicidal Thoughts. Internal consistency reliability coefficients were good-to-excellent for the total score and all three factors at baseline (a = 0.774-0.915) and exit (a = 0.849-0.941). The total score and all three factors significantly correlated with overall depression severity and suicidal ideation as rated by teens and parent (p = .704-0.756, all p < .001). The CHRT-SR was sensitive to change, with moderate to large effect sizes (Cohen's d = 0.599-1.062). LIMITATIONS: Study limitations include generalizability, lack of a control group, and retrospective data from a sample of opportunity. CONCLUSIONS: The CHRT-SR is a reliable and valid measure for examining severity of suicidal thoughts and associated risk factors, and is sensitive to change following an intervention in adolescents.
BACKGROUND: Several self-report rating scales have been developed to assess suicidal ideation, yet few examine other factors related to increased suicidal risk, and even fewer have been validated in both adolescents and adults. We evaluate the 14-item Concise Health Risk Tracking - Self Report (CHRT-SR), a measure previously validated in adults, in a sample of adolescents at risk for suicide. METHOD: Data are from a retrospective chart review of adolescents treated in an intensive outpatient program for youth with severe suicidality. Teens completed the CHRT-SR and Quick Inventory of Depressive Symptomatology - Adolescents (QIDS-A) at baseline and discharge. The CHRT-SR was evaluated to determine the factor validity, internal consistency, construct validity, and sensitivity to change. RESULTS: Adolescents (n = 271) completed the CHRT-SR prior to treatment, and 231 completed the CHRT-SR at discharge. Three factors were identified with excellent model fit: Propensity, Impulsivity, and Suicidal Thoughts. Internal consistency reliability coefficients were good-to-excellent for the total score and all three factors at baseline (a = 0.774-0.915) and exit (a = 0.849-0.941). The total score and all three factors significantly correlated with overall depression severity and suicidal ideation as rated by teens and parent (p = .704-0.756, all p < .001). The CHRT-SR was sensitive to change, with moderate to large effect sizes (Cohen's d = 0.599-1.062). LIMITATIONS: Study limitations include generalizability, lack of a control group, and retrospective data from a sample of opportunity. CONCLUSIONS: The CHRT-SR is a reliable and valid measure for examining severity of suicidal thoughts and associated risk factors, and is sensitive to change following an intervention in adolescents.
Authors: Katherine Sanchez; Michael O Killian; Taryn L Mayes; Tracy L Greer; Joseph M Trombello; Robert Lindblad; Bruce D Grannemann; Thomas J Carmody; A John Rush; Robrina Walker; Madhukar H Trivedi Journal: J Psychiatr Res Date: 2018-03-27 Impact factor: 4.791
Authors: Joseph M Trombello; Michael O Killian; Bruce D Grannemann; Augustus John Rush; Taryn L Mayes; Ramin V Parsey; Melvin McInnis; Manish K Jha; Aasia Ali; Patrick J McGrath; Phil Adams; Maria A Oquendo; Myrna M Weissman; Thomas J Carmody; Madhukar H Trivedi Journal: J Psychopharmacol Date: 2019-01-17 Impact factor: 4.153
Authors: Anjali Sankar; Priyanka Panchal; Danielle A Goldman; Lejla Colic; Luca M Villa; Jihoon A Kim; Eli R Lebowitz; Erin Carrubba; Bernadette Lecza; Wendy K Silverman; Holly A Swartz; Hilary P Blumberg Journal: Am J Psychother Date: 2021-07-23